| [Analysis of rearrangements in the first exon of c-myc oncogene in squamous cell carcinoma of the head and neck]. | HNSC, |
| Flow cytometric analysis of c-myc oncoprotein in non-small-cell lung carcinoma: comparison with immunohistochemical results. | lung, |
| Growth control of human colon-adenocarcinoma-derived Caco-2 cells by vitamin-D compounds and extracellular calcium in vitro: relation to c-myc-oncogene and vitamin-D-receptor expression. | colorectal, |
| Expression of c-myc oncoprotein in chronic T cell leukemias. | leukemia, |
| Suppression of c-myc oncogene expression by a polyamine-complexed triplex forming oligonucleotide in MCF-7 breast cancer cells. | breast, |
| Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. | brain, |
| Macrophage colony-stimulating factor is expressed by an ovarian carcinoma subline and stimulates the c-myc proto-oncogene. | colorectal,ovarian, |
| ACTH-induced c-myc proto-oncogene expression precedes antimitogenic effect during differentiation of fetal rat adrenocortical cells. | adrenocortical, |
| Immunohistochemical expression of C-myc oncogene, heat shock protein 70 and HLA-DR molecules in malignant cutaneous melanoma. | skin, |
| [Gallbladder carcinoma: expression of the c-myc and ras-p-21 oncogene products]. | bladder, |
| Estradiol stimulates c-myc proto-oncogene expression in normal human breast epithelial cells in culture. | breast, |
| Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. | breast, |
| [Inhibition of proto-oncogene c-myc expression with recombinant human tumor necrosis factor-alpha and interferon-gamma in HL-60 cell lines and acute myelocytic leukemic fresh cells]. | leukemia, |
| Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. | lymphoma, |
| Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein. | neuroblastoma, |
| Down-regulation of c-myc oncogene during NGF-induced differentiation of neuroblastoma cell lines. | neuroblastoma, |
| Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin s lymphoma. | lymphoma, |
| Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. | neuroblastoma, |
| Investigation of c-myc oncogene amplification in colorectal cancer. | colorectal, |
| Human neuroblastoma: amplification of the N-myc oncogene and loss of a putative cancer-preventing gene on chromosome 1p. | neuroblastoma, |